Skip Navigation


Carcinogenesis Advance Access originally published online on January 8, 2007
Carcinogenesis 2007 28(5):1079-1086; doi:10.1093/carcin/bgl256
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
28/5/1079    most recent
bgl256v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Lo, Y.-L.
Right arrow Articles by Shen, C.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lo, Y.-L.
Right arrow Articles by Shen, C.-Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org

Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility

Yen-Li Lo1,3, Jyh-Cherng Yu4, Shou-Tung Chen6, Giu-Cheng Hsu5, Yi-Chien Mau1, Show-Lin Yang1, Pei-Ei Wu1 and Chen-Yang Shen1,2,7,*

1 Institute of Biomedical Sciences
2 Life Science Library, Academia Sinica, Taipei 11529, Taiwan
3 Division of Biostatistics and Bioinformatics, National Health Research Institute, Chu-Nan 350, Taiwan
4 Department of Surgery
5 Department of Radiology, Tri-Service General Hospital, Taipei 114, Taiwan
6 Department of Surgery, Changhua Christian Hospital, Changhua 500, Taiwan
7 Graduate Institute of Environmental Science, China Medical University, Taichung 407, Taiwan

* To whom correspondence should be addressed. Tel: +886 2 2789 9036; Fax: +886 2 2782 3047; Email: bmcys{at}ibms.sinica.edu.tw

Aneuploidy occurs early during tumorigenesis and may contribute to tumor formation. Tumor cells become aneuploid as a result of aberrant mitotic divisions, suggesting a tumorigenic contribution of the mechanisms in maintaining chromosomal number stability. We therefore speculated that the genes TTK, MAD2L1, BUB1, BUB1B and PTTG1 (Securin), jointly implicated in the regulation of mitotic checkpoint, might be associated with breast tumorigenesis. To test this hypothesis, this case–control study of 698 primary breast cancer patients and 1492 healthy controls examined single-nucleotide polymorphisms (SNPs) in these mitotic checkpoint genes to define their tumorigenic contribution. Because estrogen is known to promote breast cancer development via its mitogenic effect leading to malignant proliferation of breast epithelium and the mitotic checkpoint genes are involved in regulating mitosis, we were also interested in knowing whether any association between genotypes and breast cancer risk was modified by reproductive risk factors. Support for these hypotheses came from the observations that (i) two SNPs in TTK and PTTG1 were associated with breast cancer risk; (ii) haplotype and haplotype combination analyses in TTK, BUB1B and PTTG1 revealed a strong association with breast cancer risk; (iii) a trend to an increased risk of breast cancer was found in women harboring a greater number of putative high-risk genotypes/haplotypes of mitotic checkpoint genes and (iv) a significant interaction between high-risk genotypes/haplotypes and reproductive risk factors in determining breast cancer risk was defined. This study provides new support for the mutator role of mitotic checkpoint genes in breast cancer development, suggesting that breast cancer could be driven by genomic instability associated with variant mitotic checkpoint genes, the tumorigenic contribution of which could be enhanced as a result of increased mitosis due to estrogen exposure.

Abbreviations: aOR, adjusted odds ratio; BMI, body mass index; CI, confidence interval; CIN, chromosomal instability; FFTP, first full-term pregnancy; FTP, full-term pregnancy; LD, linkage disequilibrium; OR, odds ratio; SNP, single-nucleotide polymorphism

Received September 27, 2006; revised November 26, 2006; accepted December 20, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
J.-C. Yu, S.-l. Ding, C.-H. Chang, S.-H. Kuo, S.-T. Chen, G.-C. Hsu, H.-M. Hsu, M.-F. Hou, L. Y. Jung, C.-W. Cheng, et al.
Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes
Carcinogenesis, September 1, 2009; 30(9): 1562 - 1570.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
S. E Ghayad, J. A Vendrell, I. Bieche, F. Spyratos, C. Dumontet, I. Treilleux, R. Lidereau, and P. A Cohen
Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer
J. Mol. Endocrinol., February 1, 2009; 42(2): 87 - 103.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S.-l. Ding, J.-C. Yu, S.-T. Chen, G.-C. Hsu, S.-J. Kuo, Y. H. Lin, P.-E. Wu, and C.-Y. Shen
Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility
Carcinogenesis, January 1, 2009; 30(1): 43 - 49.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
K.-D. Lee, S.-C. Chen, C. H. Chan, C.-H. Lu, C.-C. Chen, J.-T. Lin, M.-F. Chen, S.-H. Huang, C.-M. Yeh, and M.-C. Chen
Increased Risk for Second Primary Malignancies in Women with Breast Cancer Diagnosed at Young Age: A Population-Based Study in Taiwan
Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2647 - 2655.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
F. Salehi, K. Kovacs, B. W Scheithauer, R. V Lloyd, and M. Cusimano
Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update
Endocr. Relat. Cancer, September 1, 2008; 15(3): 721 - 743.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.